It has been proposed that T cell activation may play an important role in the pathogenesis of systemic lupus erythematosus (SLE). In order to examine this hypothesis, we assessed the whole degree of clonal accumulation of T cells using RT-PCR and subsequent single-strand conformation polymorphism (SSCP) analysis. The analysis of the β chain of the TCR revealed little clonotypic T cell expansion in the peripheral blood of lupus patients in remission, whereas in patients with active disease many dominant T cell clonal expansions without any distinct V β bias were observed. The alteration in the number of T cell clones correlated well with disease activities, since these T cell expansions decreased as patients had improved. Furthermore, similar but more intense accumulations of T cell clones were found in pleural and pericardial effusions of patients with lupus serositis. Some of these identical expanded clonotypes were observed irrespective of the lesions and the times of sampling, and some of them were identical to those observed in the peripheral blood. These results suggest that the T cell clonal expansions correlate with the disease activities and that the expansion might contribute to the pathogenic lesion formation in SLE.
Introduction
Systemic lupus erythematosus (SLE) is the prototypic autoinflammatory reactions, play a major role in the pathophysiology of SLE (5-12). immune disease, characterized by excessive autoantibody production, immune complex formation and immunologically T cells play a principal role in regulating the immune system, especially in antigen-specific immune responses (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . mediated tissue injury. Various autoantibodies such as anti-DNA, anti-RNP or anti-Sm antibodies detectable in lupus After responding to a specific antigen, restricted T cell populations with distinct clonotypes would proliferate and patients provide important clues to the etiology of SLE. Production of these autoantibodies cannot simply be form accumulated T cell clones. Therefore, to investigate an antigen-specific immune reaction, it is important to know how explained by an intrinsic B cell abnormality leading to unregulated proliferation of randomly activated B cells. Recent T cells clonally expand.
We established a novel method to determine the TCR reports suggest that autoantibody production is rather the result of a focused immune response (1) (2) (3) (4) . In fact, both clonotype (23) (24) (25) (26) (27) , using the combination of RT-PCR (29) with multiple TCR primers and subsequent single-strand epitope mapping of such autoantibodies and sequencing of Ig genes encoding for these autoantibodies strongly suggest conformation polymorphism (SSCP) (24). This system can detect dominant T cell clonotypes in terms of the complementthat antigen-specific immune responses, besides non-specific 6  active  F  30  A24  B51  CW3  DR9  DQ1  (-)  B61  (-)  DR15  DQ3  7  active  M  20  A11  B13  CW7  DR12  DQ1  (-)  B67  (-)  DR15  DQ7  8 active
HLA study of patients 1-5 (inactive SLE) was not included.
ary-determining region 3 (CDR3) nucleotide sequence differtions (patients 6-10), and the dose was reduced as lupus activity was controlled. Low-dose oral therapy (5-10 mg/day) ences. Thus, this system provides us with a powerful method for analyzing most accumulated T cell clonotypes from a was given to inactive lupus patients (patients 1-5). Their ages varied from 18 to 48 years and the duration of their disease heterogeneous population at the same time.
In the present investigation, by using this method, we ranged from 6 months to 20 years. As a control, 10 healthy individuals with no history of connective tissue diseases were performed a longitudinal study of T cell clonality in peripheral blood lymphocytes (PBL) from SLE patients, including analysis included in the study. Informed consent was obtained from all patients and healthy volunteers. of T cells in the pleural and pericardial effusions of lupus serositis. Our study yielded two new findings. First, the T cell Isolation of mononuclear cells clonality in PBL from SLE patients changed dramatically during the course of the disease and the degree of the Blood were sampled from healthy volunteers and patients accumulation of T cell clones was closely correlated with the with SLE and heparinized. Pleural and pericardial effusion disease activity. Second, the pleural and pericardial effusion was also obtained from two patients in the acute phase with contained a very intense accumulation of T cell clones, some lupus pleuritis and pericarditis by thoraco/pericardiocentesis. of which were found to be identical irrespective of the Mononuclear cells were prepared by Ficoll-Hypaque different sites of serositis lesions. Our findings suggest that (Pharmacia, Uppsala, Sweden) gradient centrifugation. Some the accumulating T cell clones are relevant to disease activity of them were separated into CD4 ϩ or CD8 ϩ subsets by and also to the formation of inflammatory lesions in SLE.
positive selection using antibody-coated magnetic beads (Dynabeads; Dynal, Oslo, Norway) according to the manufacturer's instruction before analysis. Methods
RNA isolation and cDNA synthesis Study populations
Total RNA was isolated from the cells by the AGPC method (31) Diagnosis was made by the attending physicians in the and converted to first strand cDNA using reverse transcriptase Department of Medicine and Physical Therapy, Faculty of (Superscript; BRL, Gaithersburg, MD) and a random hexamer Medicine, University of Tokyo, using the 1982 revised oligonucleotide primer (100 pmol; BRL) at 42°C for 2 h. American College of Rheumatology criteria of SLE (30) and none of the patients exhibited symptoms of other connective PCR-SSCP using TCR primers and SSCP analyses tissue diseases. Of the 10 patients studied, five (patients 1-5) were in the prolonged period of inactive phase, three PCR-SSCP was performed as described (32) . Briefly, after cDNAs were mixed with each primer set (a V β sense primer (patients 6-8) were patients with clinically active lupus with acute and severe manifestations, and patients 9 and 10 were and the C β anti-sense primer), PCRs were performed with dNTP and Taq DNA polymerase (Promega, Madison, WI) for also active lupus patients with severe serositis (Table 1) . To evaluate lupus activity, a standard scoring systems, the 35 cycles (94°C for 1.5 min, 60°C for 2 min and 72°C for 3 min). After electrophoresis in non-denaturing 4% polyacrylsystemic lupus erythematosus disease activity index (SLE-DAI), was employed. The patients' immunological indices, amide gels, the amplified products were transferred to Immobilon-S (Millipore Intertech, Bedford, MA). The filters such as antibodies to double-strand DNA (anti-dsDNA) and serum complement levels (C3 and C4) as markers of lupus were then hybridized with a biotinylated C β internal probe and visualized by subsequent incubation with streptoavidin, activity were determined. All of the patients were treated with prednisolone without other immunosuppressive agents. Highbiotinylated alkaline phosphatase and a chemiluminescent substrate system [Plex Luminescent kits; Millipore Intertech dose oral therapy (e.g. 1 mg prednisolone/kg/day) was initially given to active lupus patients with acute and severe manifesta-(24)].
high titers of anti-dsDNA antibody. The condition of these patients was improved markedly with corticosteroids and was brought under control. The points when the blood was sampled are indicated by arrows ( Fig. 2A) . In contrast to the smear pattern from inactive SLE patients, all samples from active lupus patients showed many dominant bands over the smears, ranging from 10 to 40 per sample and these accumulated T cell clonotypes were observed for nearly all the available V β s (Fig. 2B) . Further, as the disease gradually improved, T cell accumulations in PBL were reduced. The numbers of distinct bands in these three patients are shown in Table 1 . It was also found that the number of distinct bands showed a correlation with the disease activity represented by serological features and SLE-DAI (Fig. 2A) .
The accumulated T cell clonotypes in lupus pleuritis and pericarditis
Patients 9 and 10 were other active lupus patients who had clinical signs of serositis. Patient 9 presented with marked had mild bilateral pleural effusion. After other causes of the effusion such as infection had been ruled out, samples were obtained carefully from these inflammatory lesions to avoid any contamination with peripheral blood and then analyzed.
Results
All effusions showed expanded clonal T cell accumulations Peripheral T cell clonality in healthy controls and patients with (Figs 3A and 4A) . To compare the T cell clonotype from inactive SLE different sites and times, all samples were analyzed on the same SSCP gel (Figs 3B and 4B). About 78% (seven out of To investigate the accumulated T cell clonotypes in the samples of lupus patients, we performed RT-PCR and subnine) of the expanded T cell clonotypes exhibited identical migration patterns irrespective of the lesion and the time of sequent SSCP analysis, and determined heterogeneity in the junctional region of the TCR β chain. We have reported that sampling in the same patient-clones with the same sequences migrate to the same position in an SSCP analysis a heterogeneous T cell population such as PBL from healthy controls exhibits a smear pattern. In contrast, if there is an (27, 29, 33) . These findings indicate that the same expanded T cell clones exist in different compartments of serositis in expanded T cell clonotype in the population, a distinct band can be observed in the smear. Similarly, we also ascertained the same patients. Moreover,~59% (four out of seven) of these shared T cell clones could be also detected in the PBL, that antigenic stimulation in vitro or in vivo generates bands in the smear by T cell clonotype expansion (24, 26) .
especially in the CD8 ϩ subset (Fig. 4B, patient 10) , while some of the other common bands observed in the effusions Figure 1 shows T cell clonotypes of PBL from both healthy controls and inactive lupus patients (one representative were not demonstrable in peripheral blood. healthy control and the five lupus SLE patients in remission). Little difference can be seen in the pattern and the number Discussion of bands between the lupus patients and the controls except for one SLE patient. These results, together with the results
In this study we demonstrated that T cell clones accumulated in active SLE patients and that these T cell clonotypes of a follow-up study described later, suggest that most SLE patients in the inactive phase have a few distinct clonal T cell dynamically changed in accordance with the activity of the disease. Some investigators have described the TCR reperexpansions in PBL (average ϭ 2.8 clones/person). However, PBL from one patient in remission (patient 4) presented 10 toire in PBL from SLE patients by using the RT-PCR (33) (34) (35) . Nucleotide sequences of the CDR3 have been obtained from distinct dominant bands. She had no clinical symptoms and no noteworthy serological data like other stable patients, cloned T cell panels. This strategy, indeed, is effective in characterizing both the specificity and function of a T cell except maintaining a high ANA titer (1:1600), although her last relapse was Ͼ5 years ago.
clone. However, it requires more complicated steps and it has not been ascertained that established T cell clones reflect The kinetics of T cell clonality in PBL from patients with the entire repertoire of the accumulated clones (34, 35) . In active SLE this respect, the RT-PCR/SSCP method has an advantage. Although the identity and difference in CDR3 region amino Figure 2(A) shows the clinical courses of three active lupus patients (patients 6-8). Two of them (patients 6 and 7) were acid cannot be determined, it is possible to analyze whole TCR clonalities more directly and qualitatively by this method previously untreated. These patients exhibited typical clinical and serological manifestations of active SLE such as high (36-41).
The PBL of almost all lupus patients in remission showed fever, leukopenia, extremely reduced complement level and little, if any, clonal accumulation, just as seen in the healthy nature of this clonal T cell accumulation which reflects the antigen-specific immune response, it is reasonable to specucontrols. However, it is of note that the PBL of an inactive SLE patient exhibited rather extended clonal accumulation.
late that some of these clones play an important role in the pathogenesis of SLE. Since the alteration of this T cell There were no apparent differences either in the clinical manifestation or in the doses of steroid therapy received accumulation appears to correlate with the activity of the disease, these results imply that this approach has the among these SLE patients in remission, except for a relatively high ANA titer. Since a clonotype of CD8 cells, once clonally potential to monitor the lupus activity.
There is a possibility that under the high dose of prednisoexpanded, can be detected for a long time, it is possible that even in inactive lupus patients with no obvious clinical lone, steroid-induced apoptosis occurs and diminishes the size of clonal population. As a result, the decrease in the manifestations, some of the distinct clonal T cell accumulations may be maintained in their PBL.
number of lymphocytes might lead to the artificially enhanced detection of the clones. In order to avoid this possibility, we On the other hand, the PBL from lupus patients with active disease were characterized by a marked accumulation of take a sufficient amount of PBL (1-1.5ϫ10 7 lymphocytes) from the patient and use the same amount of total RNA. distinct T cell clonotypes and total lymphocyte counts were markedly decreased in these patients. Therefore, there was Furthermore, as SLE activity decreased, the number of peripheral lymphocytes quickly increased and reached a certain an inverse relationship between the number of T cells and the degree of clonal T cell accumulation. Considering the stable count, whereas the number of the accumulating T cell 1  3  3  3  3  3  3  4  3  3  2  5  69  3.1  2  4  4  3  3  3  1  4  2  3  1  2  N 3  3  1  3  2  2  1  1  1  3  50  2.3  3  3  4  3  0  0  0  3  2  3  1  0  1  1  2  0  1  0  0  0  1  0  2  28  1.3  4  0  2 The numbers indicate total count of distinctly observed T cell clones in each V β PCR product. N, only inadequate amplification was obtained by PCR.
clones decreased gradually as the SLE-DAI score decreased.
Since the early 1970s, several studies have indicated that in active SLE patients, T cells are reduced in number as Therefore, there is no direct association between the clonal size and the number of the lymphocytes.
well as function (4, 42, 43) . Many abnormalities, particularly diminished T cell proliferative responses to mitogens or to We also observed no deviation of V β usage of the expanded clones in PBL and invading lymphocytes in active SLE soluble antigens, have been reported (43, 44) . These findings have been attributed to the abnormality of the regulatory or patients, while other autoimmune diseases tend to show a more restricted oligoclonal T cell repertoire. This phenomenon inherent T cells in patients with SLE. Based on these results, some researchers have argued against any prominent or may reflect the complexity and wide range of immunological abnormalities of SLE.
positive T cell role in the pathogenesis of SLE (33, 43, 44 ated but that the response to the antigens unrelated to the
